Last reviewed · How we verify

(18F)Flutemetamol — Competitive Intelligence Brief

(18F)Flutemetamol (18fflutemetamol) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: unknown. Area: Rare Disease.

marketed unknown unknown Rare Disease Live · refreshed every 30 min

Target snapshot

(18F)Flutemetamol (18fflutemetamol) — Pfizer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
(18F)Flutemetamol TARGET 18fflutemetamol Pfizer marketed unknown unknown
SINECATECHINS SINECATECHINS marketed Polyphenols Unknown 2006-01-01
PODOFILOX PODOFILOX marketed Topical antiviral Unknown 1990-01-01
POLIDEXIDE SULFATE POLIDEXIDE SULFATE marketed Unknown Unknown 1974-01-01
SUTILAINS SUTILAINS marketed Unknown Unknown 1969-01-01
Pf-06700841 pf-06700841 Pfizer marketed Unknown Unknown
Pf-08032562 pf-08032562 Pfizer Inc. marketed unknown unknown

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (unknown class)

  1. Pfizer · 7 drugs in this class
  2. Pfizer Inc. · 3 drugs in this class
  3. Qilu Pharmaceutical Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). (18F)Flutemetamol — Competitive Intelligence Brief. https://druglandscape.com/ci/18fflutemetamol. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: